Editorial
Bibliometric analysis connecting discrete studies in nasopharyngeal carcinoma and predict future research trends
Translational Cancer Research
2023;
12
(8)
:1891-1894
.
(31 August 2023)
Original Article
Prognostic value of cancer-associated fibroblasts-related genes in lung adenocarcinoma
Translational Cancer Research
2023;
12
(8)
:1895-1911
.
(31 August 2023)
Transcriptional expression, prognostic value and immune infiltration of SFRP family in colorectal cancer: a study based on comprehensive bioinformatics and in vitro analyses
Translational Cancer Research
2023;
12
(8)
:1912-1928
.
(31 August 2023)
Induction of metallothionein expression by supplementation of zinc induces resistance against platinum-based treatment in malignant pleural mesothelioma
Translational Cancer Research
2023;
12
(8)
:1929-1936
.
(31 August 2023)
Prognostic factors and clinic-pathologic characteristics of ovarian tumor with different histologic subtypes—a SEER database population study of 41,376 cases
Translational Cancer Research
2023;
12
(8)
:1937-1950
.
(31 August 2023)
Epidemiological and survival outcomes of neuroendocrine carcinoma of the breast: a SEER data analysis
Translational Cancer Research
2023;
12
(8)
:1951-1962
.
(31 August 2023)
Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma
Translational Cancer Research
2023;
12
(8)
:1963-1979
.
(31 August 2023)
The assessment of Ki-67 for prognosis of gastroenteropancreatic neuroendocrine neoplasm patients: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(8)
:1980-1991
.
(31 August 2023)
Novel potential urinary biomarkers for effective diagnosis and prognostic evaluation of high-grade bladder cancer
Translational Cancer Research
2023;
12
(8)
:1992-2007
.
(31 August 2023)
Exploring prognostic markers for patients with acute myeloid leukemia based on cuproptosis related genes
Translational Cancer Research
2023;
12
(8)
:2008-2022
.
(31 August 2023)
Establishing a prognostic model with ferroptosis-related long non-coding RNAs in bladder cancer
Translational Cancer Research
2023;
12
(8)
:2023-2032
.
(31 August 2023)
Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer
Translational Cancer Research
2023;
12
(8)
:2033-2047
.
(31 August 2023)
Integrative analysis of the SOX family-related prognostic signature and immunological infiltration in prostate cancer
Translational Cancer Research
2023;
12
(8)
:2048-2062
.
(31 August 2023)
A novel genes-based signature with prognostic value and predictive ability to select patients responsive to Atezolizumab treatment in bladder cancer: an analysis on data from real-world studies
Translational Cancer Research
2023;
12
(8)
:2063-2070
.
(31 August 2023)
A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma
Translational Cancer Research
2023;
12
(8)
:2071-2098
.
(31 August 2023)
Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma
Translational Cancer Research
2023;
12
(8)
:2099-2114
.
(31 August 2023)
The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(8)
:2115-2127
.
(31 August 2023)
Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study
Translational Cancer Research
2023;
12
(8)
:2128-2137
.
(31 August 2023)
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients
Translational Cancer Research
2023;
12
(8)
:2138-2154
.
(31 August 2023)
Risk factors for the occurrence of infection in patients with oral squamous cell carcinoma after restorative reconstruction and its impact on recurrence and quality of life: a retrospective cohort study
Translational Cancer Research
2023;
12
(8)
:2155-2168
.
(31 August 2023)
Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(8)
:2169-2180
.
(31 August 2023)
Review Article
A narrative review: progress in transition metal-mediated bioorthogonal catalysis for the treatment of solid tumors
Translational Cancer Research
2023;
12
(8)
:2181-2196
.
(31 August 2023)
The treatment of patients with non-small cell lung cancer carrying uncommon EGFR mutations, HER2 mutations, or brain metastases: a systematic review of pre-clinical and clinical findings for dacomitinib
Translational Cancer Research
2023;
12
(8)
:2197-2211
.
(31 August 2023)
Case Report
A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case report
Translational Cancer Research
2023;
12
(8)
:2212-2218
.
(31 August 2023)
Editorial Commentary
Breast cancer disparities among sexual and gender minority populations
Translational Cancer Research
2023;
12
(8)
:2219-2223
.
(31 August 2023)
Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
Translational Cancer Research
2023;
12
(8)
:2224-2228
.
(31 August 2023)
Is there a role for stereotactic body radiation before immune checkpoint inhibitor therapy for advanced hepatocellular carcinoma?
Translational Cancer Research
2023;
12
(8)
:2229-2231
.
(31 August 2023)
Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
Translational Cancer Research
2023;
12
(8)
:2232-2234
.
(31 August 2023)
